Arrayit Licenses Microarrays, Reagents to Belmedtechnika | GenomeWeb

NEW YORK (GenomeWeb News) — Arrayit has licensed its microarray platform and associated reagents to Belmedtechnika, an equipment provider in Belarus, Arrayit said yesterday.

Arrayit, a subsidiary of Integrated Media Holdings, said that Belmedtechnika will deploy its high-throughput genotyping platform to screen and test number patient samples "quickly, affordably, and accurately."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.